Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Huahui Health clinical trials
The registry lists 18 studies whose lead sponsor is Huahui Health. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Keep track of what changes. Save the Huahui Health studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Huahui Health.
- Huahui Health18 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 18 of 18.
- A Clinical Study of HH-1270 in Healthy Chinese SubjectsNot yet recruitingNCT07876440Phase 1
- A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)RecruitingNCT07499544Phase 3
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT07623369Phase 1
- A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCCRecruitingNCT07547553Phase 1/2
- Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus InfectionRecruitingNCT07519330Phase 2
- A Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus InfectionCompletedNCT05861674Phase 2
- HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2CompletedNCT05787418Phase 3
- A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid TumorsCompletedNCT07554196Phase 1
- A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected PatientsCompletedNCT07515209Phase 1
- A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level ViremiaCompletedNCT05734807Phase 2
- A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19CompletedNCT05713318Phase 2
- A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and Hepatitis D Co-infectionTerminatedNCT05674448Phase 2
- A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase InhibitorsCompletedNCT05839639Phase 2
- A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy VolunteersCompletedNCT05753878Phase 1
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy VolunteersCompletedNCT05116865Phase 1
- A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19CompletedNCT06039163Phase 1
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy VolunteersCompletedNCT05275465Phase 1
- A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05542979Phase 1